General Comments / Chat, page-10466

I'm just wondering if we've overlooked some important research highlighting the efficancy of bisantrene in dentistry ???

Noting our Program Management, Risk & Strategy Director is presenting at at the upcoming Australian Dental Industry Association’s Conference next month at the Avant Dental Learning Lab in partnership on the ‘Future of Healthcare and the Digitally Enabled Patient’




I might be missing something here, but how does this relate to RAC & bisantrene ?? Wouldn't a better audience be any of the numerous Cancer foundations, charities & research bodies, medical associations, etc, etc and topic related to our drug and the future of oncology, etc, for example. Shouldn't RAC staff be speaking on topics directing relating to bisantrene & Race Oncology. Dentistry ffs !!??

@Davisite with all due respect, this appears to be seriously misguided & a poor use of our personnel.